Junichiro Fujimoto
Tokyo, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications
Phase II Clinical Trial for Newly Diagnosed Children and Adolescents with Localized Lymphoblastic Lymphoma (Japanese Leukemia/Lymphoma Study Group Trial LLB-NHL03) : Study Protocol for Nationwide Multicenter Trial.
Journal: Acta medica Okayama
Published: August 25, 2018
Secondary cancer after a childhood cancer diagnosis: viewpoints considering primary cancer.
Journal: International journal of clinical oncology
Published: April 17, 2018
Secondary bone/soft tissue sarcoma in childhood cancer survivors: a nationwide hospital-based case-series study in Japan.
Journal: Japanese journal of clinical oncology
Published: April 03, 2018
Clinical Features and Prognosis According to Immunophenotypic Subtypes Including the Early T-Cell Precursor Subtype of T-Lymphoblastic Lymphoma in the Japanese Pediatric Leukemia/Lymphoma Study Group ALB-NHL03 Study.
Journal: Journal of pediatric hematology/oncology
Published: May 25, 2017
Intensified and prolonged therapy comprising cytarabine, vincristine and prednisolone improves outcome in patients with multisystem Langerhans cell histiocytosis: results of the Japan Langerhans Cell Histiocytosis Study Group-02 Protocol Study.
Journal: International journal of hematology
Published: December 26, 2015
Secondary cancers after a childhood cancer diagnosis: a nationwide hospital-based retrospective cohort study in Japan.
Journal: International journal of clinical oncology
Published: September 09, 2015
Prognostic Impact of Intensified Maintenance Therapy on Children With Advanced Lymphoblastic Lymphoma: A Report From the Japanese Pediatric Leukemia/Lymphoma Study Group ALB-NHL03 Study.
Journal: Pediatric blood & cancer
Published: May 18, 2015
Prognostic impact of cytogenetic abnormalities in children and adolescents with mature B-cell non-Hodgkin lymphoma: A report from the Japanese Pediatric Leukemia/Lymphoma Study Group (JPLSG).
Journal: Pediatric blood & cancer
Published: September 18, 2014
Clinical initiatives linking Japanese and Swedish healthcare resources on cancer studies utilizing Biobank Repositories.
Journal: Clinical and translational medicine
Published: September 11, 2014
EVI1 overexpression is a poor prognostic factor in pediatric patients with mixed lineage leukemia-AF9 rearranged acute myeloid leukemia.
Journal: Haematologica
Published: July 13, 2014
Statistical analysis of relation between plasma methotrexate concentration and toxicity in high-dose methotrexate therapy of childhood nonHodgkin lymphoma.
Journal: Pediatric blood & cancer
Published: May 22, 2014
Last Updated: 09/26/2026